Embryonic stem cells come from very early-stage embryos, usually created in fertility clinics and donated for research once they are no longer needed for reproduction.

Quick Scoop

What they are

  • Embryonic stem cells are pluripotent , meaning they can turn into almost any cell type in the body.
  • They are taken from the “inner cell mass” of a structure called a blastocyst, which is a tiny hollow ball of cells about five days after fertilization.

Where they come from

  • Most human embryonic stem cells used in research come from surplus embryos created during in vitro fertilization (IVF) treatments and later voluntarily donated with informed consent.
  • At the blastocyst stage (around 3–5 days after fertilization), the embryo has about 150 cells; a few inner cells are carefully removed and grown in the lab as an ongoing stem cell “line.”

Why this is a big topic

  • Because obtaining embryonic stem cells usually destroys the early embryo, their use raises ethical and legal debates about the moral status of early human life.
  • At the same time, their unique ability to become many specialized tissues makes them central to research on diseases like Parkinson’s, diabetes, heart damage, and spinal cord injury.

TL;DR: Embryonic stem cells are pluripotent cells taken from the inner cell mass of 3–5-day-old IVF embryos that are donated for research after fertility treatment, which is why they are both scientifically promising and ethically debated.

Information gathered from public forums or data available on the internet and portrayed here.